Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefu Zhuyu Capsule for postoperative chest pain after thoracoscopic lung resection in early non-small cell lung cancer
ChiCTR1900024649Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of xuefu zhuyu in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: NRS numeric rating scale. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
xuefu zhuyu
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR1900024649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024649.